Animal tumor models and human cancer studies have provided convergent evidence that chronic psychological stress plays a decisive role in modulating anti-tumor T cell immunity. However, whether chronic stress also affects anti-cancer vaccine strategies that rely on the induction of functional tumorspecific T CD8+ cells has not been investigated yet. In this study we provide direct evidence that chronic stress suppresses the therapeutic efficacy of a biodegradable poly(D,L-lactide-co-glycolide) microsphere (PLGA-MS) based cancer vaccine in a murine melanoma model. Exposure of mice to social disruption stress (SDR), a well-established model mimicking psychological chronic stress in humans, significantly impaired tumor protection in response to cancer vaccination under both prophylactic and therapeutic conditions. Vaccine failure in stressed mice correlated with significantly reduced generation of interferon-c (IFN-c)-producing T CD8+ effectors and CTL-mediated killing. Phenotypic analysis of dendritic cells (DCs) revealed that both migratory and lymphoid-resident DCs failed to undergo full maturation upon antigen uptake. Notably, decreased DC maturation was associated with a significant impairment of peripheral DCs to migrate to draining LNs and to prime subsequent T CD8+ responses in vivo. In conclusion, chronic stress represents an important factor mediating immunosuppression in cancer-vaccinated hosts by impairing DC functions and subsequent T CD8+ priming. Potentially, the mechanistic insights gained in this study open new avenues in utilizing the full potential of anti-cancer vaccination strategies.
Introduction
Cancer vaccines are considered the most innovative immunotherapeutic strategies for treating or preventing the recurrence of malignancy, as they offer distinct advantages such as high specificity, reduced toxicity, and potential long-term effects via immunological memory (Mellman et al., 2011) . Several promising cancer vaccination strategies have been developed that are now studied in clinical trials for various cancer types (Guo et al., 2013) . However anti-tumor T CD8+ responses to vaccines currently tested in the clinic are often of low magnitude and many cancer patients do not establish sufficient T CD8+ effector cells necessary for tumor regression. To date immunosuppressive mechanisms limiting anti-tumor responses are complex and not fully understood (Eng et al., 2014) . In order to better realize the potential of anti-cancer vaccine strategies, more efforts should be dedicated towards understanding the causes and mechanisms that impair vaccine-induced anti-tumor immunity.
Chronic psychological stress is associated with suppressed immune-responsiveness and, as such, leads to increased susceptibility to malignancies, infections, and a poor response to vaccines (Segerstrom and Miller, 2004) . Recent evidence reveals that chronic stress-associated immunosuppression may also be of clinical significance for cancer disease and therapy (Eng et al., 2014; Antoni et al., 2006) . For example, patients diagnosed with cancer are known to experience severely increased stress, and prior studies have found a strong correlation between stress and impaired Tcell functions and NK cell cytotoxicity in patients with breast and ovarian cancer (Andersen et al., 1998; Lutgendorf et al., 2005; Thornton et al., 2007) . Animal models using chronic stressors that promote fear or anxiety have provided further evidence for stressdependent suppression of tumor-specific T CD8+ responses. For example, in a murine T cell lymphoma model immobilization stress suppressed tumor-specific cytotoxic responses and secretion http://dx.doi.org/10.1016/j.bbi.2017.04.021 0889-1591/Ó 2017 Elsevier Inc. All rights reserved.
